To study whether renal sympathetic denervation(RSD) will reduce the all-cause mortality and
the recurrence rate of a composite of cardiovascular event(including angina, myocardial
infarction, repeat percutaneous coronary intervention and coronary artery bypass grafting) in
patients after percutaneous coronary intervention(PCI). Besides whether RSD can reduce the
risk factors for coronary heart disease.